PeterMD’s injectable offer and Henry Meds’ testosterone program make different starting points for a comparison. PeterMD emphasizes payment tiers for a named injectable treatment. Henry distinguishes compounded treatment from an oral option and describes several included services. The smallest monthly number does not capture those differences.
We checked the providers’ public information on September 22, 2026. This is a comparison of documented offers, not firsthand treatment or a test of clinical results. It leaves room for the assessing clinicians to recommend different products, further evaluation, or no testosterone prescription at all.
KEEP IN MIND
A few things to remember.
- PeterMD’s discounted injectable rates require upfront payment.
- Henry describes a bundle with separate compounded and oral offers and stated eligibility limits.
- Compare the exact prescription and complete terms before treating one monthly figure as better value.
Check the offer’s restrictions before comparing price
PeterMD’s injectable page excludes Alabama and Idaho. Henry’s FAQ lists a male age range of 35–65 with clinical criteria, and its oral Kyzatrex offer is unavailable in California. These limits apply to different parts of the services and should remain attached to the descriptions.
Ask whether the actual program and evaluating clinician are available to you. The PeterMD review and Henry review explain the checked terms without treating enrollment criteria as universal medical rules. A cheaper offer is not useful if the relevant pathway is unavailable.
Sources: PeterMD: injectable testosterone plans, payment terms, and state exclusions · Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ
Separate an equivalent monthly rate from a monthly bill
PeterMD’s discounted annual and six-month injectable plans are described as billed upfront. Its monthly offer also contains inconsistent total-price text that needs clarification. Request the exact initial charge, period covered, and renewal arrangement before using the advertised rate in a budget.
A longer payment period may fit some readers and create difficulty for others. The cost planner can organize confirmed amounts, but it cannot decide which contract terms apply or reconcile a contradictory sales page. Keep the provider’s written explanation alongside any calculation.
Sources: PeterMD: injectable testosterone plans, payment terms, and state exclusions
Ask what Henry’s bundle includes for the proposed treatment
Henry advertises compounded testosterone treatment from $129 monthly and oral Kyzatrex at $179. It describes visits, laboratory work, medication, supplies, shipping, and support within the offer. Ask whether those inclusions cover the actual plan the clinician proposes and what additional evaluation could add to the bill.
The total-cost shortlist explains why a bundle should be compared with another quote containing the same services. Do not add included medication twice, or assume that PeterMD’s injectable headline and Henry’s oral price refer to interchangeable treatment choices.
Sources: Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ
Understand the finished medicine
PeterMD names testosterone cypionate, while Henry distinguishes a compounded offer from a named oral product. For either service, request the exact prescription, dispensing pharmacy, and clinical reason for the route. A provider’s general treatment description does not establish every patient’s product or its suitability.
Compounded preparations are not FDA-approved. The medicine and pharmacy guide helps you ask about that distinction without assuming all injectable or oral options have the same evidence, precautions, or instructions. The clinician should explain the choice rather than leaving the price to make it.
Sources: PeterMD: injectable testosterone plans, payment terms, and state exclusions · Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ · FDA: understanding the risks of compounded drugs
Read the cancellation language before relying on monthly pricing
Henry uses no-long-term-contract wording while its FAQ describes possible remaining balances on multi-month plans unless a provider determines a medical inability to continue. PeterMD’s individual governing agreement and refund rights were not verified in this research. Neither offer supports a blanket promise of unrestricted cancellation.
Ask what happens if the assessment does not lead to prescribing, if the clinical plan changes, or if you leave later. Request the term, renewal date, and any remaining obligation. Understanding those answers before enrollment is more useful than assuming that a monthly label establishes a one-month commitment.
Sources: Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ · PeterMD: injectable testosterone plans, payment terms, and state exclusions
Keep assessment and follow-up central
The medical discussion should connect symptoms, repeat confirmation of low testosterone, and evaluation of the cause. Fertility goals belong in the conversation before treatment. Our first-conversation guide and fertility questions can help you prepare.
Also ask who explains results and reviews benefit, adverse effects, blood pressure, and blood counts. The follow-up guide focuses on those continuing responsibilities. This comparison can clarify public offer differences; it cannot establish which clinician, medicine, or payment plan is right for an individual reader.
Sources: Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 22, 2026; prices and availability can change.
- PeterMD: injectable testosterone plans, payment terms, and state exclusions
- Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ
- FDA: understanding the risks of compounded drugs
- Endocrine Society: testosterone therapy clinical guidance
- FDA: 2025 testosterone labeling and blood pressure changes
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.